✦ LIBER ✦

BRCA2 mutations substitute for wild type p53 in ovarian cancers with ZMIZ1 overexpression

✍ Scribed by M. Decker; N. Nadkarni; T. Neff; L. Rogers; S. Park; D. Bender; A. Ahmed; K. DeGeest; A. Dupuy; M. Goodheart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zmiz1 is overexpressed in epithelial ova

✍ N. Nadkarni; L. Rogers; M. Samuelson; T. Neff; D. Bender; A. Ahmed; K. De Geest; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Beyond BRCA1 and BRCA2 wild-type breast

✍ A Blanco; B Graña; L Fachal; M Santamariña; J Cameselle-Teijeiro; C Ruíz-Ponte; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

Intron variants of the p53 gene are asso

✍ Wang-Gohrke, S; Weikel, W; Risch, H; Vesprini, D; Abrahamson, J; Lerman, C; Godw 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

p53 and WAF1 polymorphisms in Jewish-Isr

✍ Daniel Yair; Gilad Ben Baruch; Angela Chetrit; Tal Friedman; Galit Hirsh Yechezk 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

2-Deoxyglucose combined with wild-type p

✍ Iman M. Ahmad; Maher Y. Abdalla; Nukhet Aykin-Burns; Andrean L. Simons; Larry W. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 627 KB

Cancer gene therapy mediated by CTS1, a

✍ Bougeret, Cécile; Virone-Oddos, Angela; Adeline, Emmanuelle; Lacroix, Frédéric; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 907 KB